Serafimova, Teona

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Munro, A. P. S., Feng, S., Janani, L., Cornelius, V., Aley, P. K., Babbage, G., Baxter, D., Bula, M., Cathie, K., Chatterjee, K., et al. (2022) · The Lancet Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 175

Loneliness and mental health in children and adolescents with pre‐existing mental health problems: A rapid systematic review

Hards, E., Loades, M. E., Higson‐Sweeney, N., Shafran, R., Serafimova, T., Brigden, A., Reynolds, S., Crawley, E., Chatburn, E., Linney, C., et al. (2022) · British Journal of Clinical Psychology

Child and Adolescent Psychosocial and Emotional DevelopmentCOVID-19 and Mental Health

Cited by 162

Digital Behavior Change Interventions for Younger Children With Chronic Health Conditions: Systematic Review

Brigden, A., Anderson, E., Linney, C., Morris, R., Parslow, R., Serafimova, T., Smith, L., Briggs, E., Loades, M., & Crawley, E. (2020) · Journal of Medical Internet Research

Digital Mental Health InterventionsMobile Health and mHealth Applications

Cited by 63